Antianginal Drugs Flashcards

1
Q

Fixed (Stable, Classic) Angina

A
  • Precipitated by exercise and/or excitement. Stable angina is relieed by rest. It is caused by obstruction in one or more of the coronary arteries, and the lesion is usually artherosclerotic.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Variant Angina (Prinzmetal’s Angina)

A
  • Occurs at rest or even during sleep and is unpredictable. It is caused by vasospasm of an artery that is probably injured.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Unstable Angina (Acute coronary syndrome)

A
  • Rapidly progressing of the frequency and severity of angina attack, and in the initial stages, indistinguishable from impending myocardial infarction. The condition is believed to be caused by combination of atherosclerotic plaque and thrombosis and spasm. Symptoms may occur during resting state and are unpredictable. It should be treated as a medical emergency.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Silent Ischemia

A
  • Ischemia of myocardium w/o pain or symptoms. ECG detects the episode of angina.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Nitrates/Nitrites pharmacological effects

A
  • Increase coronary blood flow; increasing O2 supply
  • Vasodilators; increases blood velocity and flow rate in normal vessels, but less of a response in stenotic vesses, which shunt blood from the ischemic area to an already adequately perfused area of the heart. This “steal effect” will exacerbate tha angina attack.
  • Decrease cardiac work; decrease preload (venodilation- primary effect, decreases left ventricular filling pressure) and afterload (arteriolar dilation- reduces peripheral resistance and impedance to left ventricular outflow); decreasing O2 demand
  • Relieve coronary artery spasm
  • Anti-platelet aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Calcium Channel Antagonist Pharmacological Effects

A
  • Increase coronary blood flow; increasing O2 supply
  • Vasodilators; increase blood velocity and flow rate in normal vessels, but less of a response in stenotic vessels, which shunt blood from the ischemic area to an already adequately perfused area of the heart. This “steal effect” will exacerbate the angina attack
  • Decrease cardiac work; decrease afterload, heart rate and contractility; decreasing O2 demand
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Beta-adrenergic Blockers Pharmacological Effects

A
  • Decrease heart rate and contractility; decreasing O2 demand
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Nitrates and Nitrite Drugs

A

Rapidly acting agents used to terminate an acute attack of angina

  • Nitroglycerin- given sublingual (0.15-0.6mg), IV, and oral spray (0.4mg)
  • Isosorbide Dinitrate- given sublingual

Agents w/ prolonged action used to prevent attacks of angina and are given orally and topically

  • Oral, sustained release of nitroglycerin
  • Nitroglycerin Transdermal (2.5-15mg/24hrs)
  • Isosorbide Dinitrate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nitrates and Nitrites MOA

A
  • Nitric Oxide activates guanylyl cyclase to produce cGMP (second messenger) to promote dephosphorylation of myosin light chain resulting vascular smooth muscle relaxation (i.e., vasodilation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nitrates and Nitrites Pharmacokinetics

A
  • Low oral bioavailability (10-20%) extensive hepatic metabolism; t1/2 = 2-8min.; however, active metabolites (eg dinitroglycerins) of nitroglycerin have a t1/2 = 3hrs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nitrates and Nitrites Tolerance

A
  • Repeated administration leads to tolerance manifested by the need of higher doses to produce the same effect. there is also cross tolerance b/w various compounds of this class. Ensure nitrage-free interval (at least 8h) to prevent tolerance
  • Mechanism: depletion of cysteine stores in vessels during the conversion to S-nitrosothiol, but may be reversed w/ sulfhydryl-regenerating agents
  • “Rebound phenomenon”: should use a graduale withdrawal after chronic therapy to avoid myocardial ischemia and death
  • “Monday Disease”: industrial disease caused by chronic exposure to organic nitrates in the workplace; characterized by headache, dizziness, and tachycardia on Monday when workers reture to work afte 2 day absence, then develop tolerance duing the work week
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Nitrates and Nitrites Adverse Reactions

A
  • Throbbing headache (meningeal artery vasodilation), flushin, postural (orthostatic) hypotension (venodilator effect)
  • Reflex tachycardia
  • Caution: nitrates/nitrites w/ sildenafil can cause severe hypotension, even myocardial infarctions. It is recommended that at least 6hrs pass b/w use of a nitrate and the ingestion of sildenafil.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Nitrates and Nitrites Therapeutic Uses

A
  • Terminate acute attackes of angina: sublingual nitroglycerin (or sublingual isosorbide dinitrate)
  • Stable angina
  • Variant angina
  • Unstable angina
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Calcium Channel Blockers Pharmacological Effects

A
  • Decrease myocardial contractility to reduce O2 requirement (mainly verapamil, diltiazem)
  • Decreased arteriolar tone results in decreased afterload
  • Dilate coronary and relief of coronary artery spasm
  • Principally used as prophylactic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Calcium Channel Blocker Drugs

A
  • Non-dihydropyridine: Verapamil, Diltiazem
  • Dihydropyridine: Nifedipine, Amlodipine (avoid short-acting dihydropyridine agents for angina)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Calcium Channel Blockers MOA

A
  • Inhibition of L-type calcium channels (heart and smooth musle). Dihydropyridines (eg, nifedipine) are more potent vasodilators and have less inhibition on cardiac contractility compared to verapamil and diatiazem; also may produce reflex tachycardia
17
Q

Calcium Channel Blockers Adverse Effects

A
  • Flushing, dizziness, nausea, constipation (common for verapamil), peripheral edema; high doese of non-dihydropyridine Ca channel blocker may cause cardiac depressant effects, such as heart failure (particular caution w/ combining w/ beta blockers), AV blockage and sinus node depression
18
Q

Calcium Channel Blockers Therapeutic Uses

A
  • Variant angina and stable angina
19
Q

Beta adrenergic Blockers Pharmacological Effects

A
  • Not vasodilators (except carvedilor and nebivolol)
  • Decreased myocardial contractility and heart rate to reduce myocardial oxygen requirement at rest and during exercise
  • Lower heart rate is assoc. w/ an increase in diastolic perfusion time leading to an increase in myocardial perfusion thereby reducing symptoms
  • Principally used as prophylactic
20
Q

Beta adrenergic Blocker Drugs

A
  • Propranolol
  • Metoprolol
  • Atenolol
21
Q

Beta-adrenergic Blockers MOA

A
  • Inhibition of beta adrenergic receptors (heart muscle)
22
Q

Beta-adrenergic Blockers Adverse Effects

A
  • Undesirable effects: increase in end-diastolic volume and increase in ejection time tend to increase myocardial oxygen demand
  • Fatigue, impaired exercise tolerance, insomnia, erectile dysfunction, cardiac depressant effects when combining w/ non-dihydropyridine Ca channel blocker
23
Q

Beta-adrenergic Blockers Therapeutic Uses

A
  • Stable and unstable angina
  • B1-selective agents preferred (i.e., atenolol, metoprolol), avoid agents w/ intrinsic sympathomimetic activity (i.e., pindolol)
24
Q

Nitrates, Nitrates with Beta Blocker and Nitrates w/ Calcium Channel Blockers in Angina Pectors Chart

A
25
Q

Ranolazine

A
  • Inhibitor of late phase of the sodium current; reduces intracellular sodium and calcium overload, thereby improving diastolic function. Also may modify fatty acid oxidation.
  • Has antianginal as well as antiarrhythmic properites. It is indicated for the treatment of chronic angina and may be used alone or in combination w/ other antianginal therapies.
  • Can prolong the OT interval and should be avoided w/ other drugs that cause QT prolongation
26
Q

Trimetazidine

A
  • Metabolic modulator
  • pFOX inhibitors which partially inhibit the fatty acid oxidation pathway in myocardium to reduce oxygen requirement per unit of ATP production
  • Demonstrate efficacy in stable angina but not approved for use in USA
27
Q

Ivabradine

A
  • Inhibits If sodium current in SA node to reduce heart rate and consequently decreases cardiac work
28
Q

Summary Chart

A